Norbrook has announced the re-launch of its range of intramammary tubes for lactating and dry cows, to promote holistic herd health and responsible use of antimicrobials.
The company’s range, which includes products across a number of antibiotic classes, primarily targets clinical cases of mastitis in lactating cows, and removal or prevention of infection around the dry period.
Chris Geddes MRCVS, Marketing Manager at Norbrook, says the re-launch is focused on modernising the range and making it clearer for practice staff and farmers to avoid confusion between lactating cow and dry cow products: “We have a wide range of 11 products containing a variety of antimicrobials: for example Duofast is the only lactating cow product to contain trimethoprim and sulfadiazine. We are working with vets to promote responsible use by farmers, for example through the use of our teat sealant Noroseal for Selective Dry Cow Therapy."
The full range includes Duofast, Lactaclox, Cefimam LC, Combiclav, Noroclav and Multiject for the lactating cow; Cefimam DC, Noroclox, Bovaclox and Bovaclox DC Xtra for the dry cow; and teat sealant Noroseal.
Norbrook has also produced a best practice guide to mastitis control, available for vets in English and Polish, which can be shared with farmers.
Chris added: "We recognise the need to reduce overall use of antimicrobials, especially for disease prevention – as well as using non-antimicrobial products such as teat sealants. These practices, together with the recent focus on using older classes of antimicrobials, mean that as an industry we need to adopt a holistic and targeted approach to herd health management.
"We believe that by providing additional information to aid with prevention of disease, and re-launching our intramammary range to make it clearer when products should be used, we can help to achieve that."
Norbrook says the full range of products is in stock, but some wholesalers may hold components of the old range as the new range is phased in.
On the 15th anniversary of the foot and mouth disease (FMD) outbreak, the BVA has emphasised the vital role of vets and veterinary surveillance in protecting the UK from devastating disease outbreaks.
The outbreak (confirmed in an abattoir on 19 February 2001) involved the slaughter of more than six million animals causing dire emotional and financial impacts on farmers, vets and rural businesses. Vets from across the profession, including those not working with livestock, were called upon to assist with disease control.
BVA is marking the anniversary by asking the government to reflect on the vital role of vets and veterinary surveillance after Defra was asked to make a further 15% budget cut in last year’s Autumn Statement (November 2015).
BVA President Sean Wensley said: "15 years on from the devastation of the 2001 outbreak the UK must remain vigilant for Foot and Mouth Disease, but important lessons learned mean we are now better prepared if another outbreak does occur. Today we would have an immediate standstill on livestock movements, improved traceability systems and the possibility of using vaccination as part of the overall control strategy. But we cannot be complacent and the anniversary is an opportunity to reflect on the vital role of vets and veterinary surveillance in protecting the UK from disease.
"In recent years we have seen the impact of significant cuts to Defra's budget on veterinary fees for TB testing and other OV services. Vets’ frontline roles must be recognised and supported, backed up by an effective, coordinated system of data capture that will enable us to make the necessary links to detect and control new disease threats. We can never be free from the risk of disease, and in recent years the emergence of Schmallenberg and re-emergence of Bluetongue have brought new challenges. It is essential that we have the coordination and capability to identify and diagnose in order to protect our national herd and flock."
Ceredigion veterinary surgeon Robert Alun Merfyn Evans has been suspended from the Register for six months by the RCVS Disciplinary Committee after he admitted to misconduct relating to tuberculin testing for cattle he owned and failing to register the births and deaths of cattle.
Mr Evans appeared before the Committee on the 11th February, when he admitted the two heads of charge of misconduct against him.
The first head of charge related to the fact that, between 24 June and 29 June 2013, he deliberately failed to bring to attention of Wyn Lewis MRCVS, an Official Veterinarian (OV) and fellow director of Mr Evans’ practice in Cardigan, the cattle on his farm requiring intradermal comparative tuberculin tests; that he tested certain of the cattle himself despite not being the OV for those tests and having a conflict of interest; and that he provided inaccurate and incomplete information to his practice for the completion of a report on the testing to be sent to the Animal Health and Veterinary Laboratories Agency (AHVLA). This misconduct was then repeated the following year between 19 June and 1 August 2014.
The second head of charge against Mr Evans related to breaches of the Cattle Identification (Wales) Regulations 2007 between 4 July 2005 and 20 June 2014, namely the fact that he failed to register the birth of five calves and the death of nine cows. These were accepted as being specimen charges reflecting a much larger total number of breaches over the whole nine year period.
Mr Evans’ misconduct first came to light when a late return was sent to the AHVLA in August 2014 regarding the TB testing of 51 live animals on his farm in June 2014. When the report was scrutinised the AHVLA noticed that 26 animals shown on the return as dead were still registered, while 20 animals that were tested were not registered. When the AHVLA investigated, Mr Evans immediately admitted that he had misled Mr Lewis on two occasions and carried out his own testing despite not being the OV.
The Committee heard that he did this because he did not want it to be found out that he had unregistered cattle on his farm. Regarding the unregistered cattle, the Committee heard that this stemmed from a mistake made by Mr Evans in 2005 or 2006 whereby he mislaid a batch of around nine bovine passport application forms sent to him to register the birth of calves on his farm, a legal requirement for the purposes of animal health, disease control and safeguarding the food chain.
As a result of poor IT skills and being profoundly deaf, Mr Evans felt unable to seek support online or by telephone, was too embarrassed to tell others and, furthermore, felt that it was impossible to correct his mistake without being in breach of the law. So, for a period of nine or 10 years, he failed to register the birth of calves on his farm. His failure to register the deaths of cattle, was also caused by administrative failings. His breaches of the cattle registration regulations were subject to criminal proceedings and on 14 October 2015 he plead guilty at Ceredigion and Pembrokeshire Magistrates Court to 14 offences for which he was given a conditional discharge for 18 months and ordered to pay costs of £1,000.
The Committee considered that a suspension from the Register would be in line with the seriousness of the charges against Mr Evans. Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: "The Committee agrees that the lengthy period over which these offences took place, his betrayal of his colleague, and the undermining of the reputation of the profession and of the system of disease control, taken together with his dishonesty, make it impossible to impose a lesser sanction than suspension.
"The Committee finds that the respondent, who is a man of good character, has fully accepted his guilt, and has real insight into the seriousness of his conduct. He cooperated fully with the investigations and with the County Council who prosecuted him in the Magistrates [Court], and with the College. He made an open and frank admission about his misconduct from the outset.
"The course of conduct on which he embarked and which has led to these charges was the result of a simple mistake at a time of considerable stress to him. He was not guilty of deliberate misconduct at the outset but… what started as an innocent mistake took on a life of its own and led him to deliberate and dishonest misconduct because he did not know how to get himself out of the predicament he was in."
Professor Barr also said that there was no financial gain in Mr Evans’ actions and that animal welfare had not been compromised as the cattle were well cared for and in good health and that Mr Evans’ actions in carrying out the tuberculin tests on the unregistered cattle himself demonstrated that he was concerned about identifying any disease in his herd.
He added: “In all the circumstances the Committee has decided a proportionate sanction is that the respondent’s registration should be suspended for a period of six months.”
The Committee’s full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
A recent UK Mastitis Panel meeting, sponsored by MSD Animal Health, has concluded that a lack of expertise in drying off and teat sealant administration is the limiting factor preventing more widespread adoption of selective dry cow therapy protocols in UK dairy farms
The panel representing practising dairy vets, research and Government agreed that whilst the use of selective dry cow therapy was at a relatively low level in UK dairy herds at the moment, a momentum was building that could see as many as half the nation’s herds adopting the practice within a few years.
Dr Martin Behr, technical manager at MSD Animal Health and chair of the UK Mastitis Panel meeting, said: "There is growing pressure from the milk processors and some supermarkets to see a reduction in antibiotic use on dairy farms, and dry cow therapy is one area under the spotlight.
"We know from our own training workshops with vets and farmers that the level of expertise in administering teat sealants, for example, is relatively low. Only about 30 percent of vets attending these workshops had any experience at all in administering a teat sealant."
The view from many on the mastitis panel was that there was a knowledge gap on farms when it comes to dry cow therapy protocols and that this presented a significant opportunity for vet practices.
Dr Behr added: "Mastitis control in general offers vets an opportunity for proactive engagement with farmers, but it is a notoriously difficult area to establish routine work. With the pressure on farms to adopt selective dry cow therapy and the need for training, there is perhaps a new opportunity for practices with a real interest in mastitis control to build stronger and more preventative strategies with dairy farmers."
Veterinary practices with an interest in training on dry cow therapy and teat sealant use are advised to contact their MSD Animal Health account manager for details of future workshops.
Virbac has launched of Bovigen Scour, an emulsion for injection into cattle which reduces the severity of diarrhoea caused by bovine rotavirus, bovine coronavirus and enteropathogenic E.coli F5 (K99).
Bovigen Scour works by actively immunising pregnant cows and heifers and providing passive immunity to their calves via colostrum. According to the company, the vaccine also helps to reduce the shedding of virus by calves infected with bovine rotavirus and coronavirus.
Virbac says a key benefit of Bovigen Scour is the vaccination protocol which offers a large window for injection, making it easier for vaccination planning. The primary course is administered in two shots, with first dose between 12 and 5 weeks before calving and the booster 3 weeks later. The annual booster is then due between 12 and 3 weeks before calving is expected. The vaccine is presented in two sizes: 15ml (5 doses) and 90ml (30 doses). The dosage per cow is 3 ml and the withdrawal time is nil in milk.
Virbac Large Animal Product Manager Brigitte Goasduf MRCVS said: "Bovigen Scour offers farmers flexibility and ease of use. The flexibility it gives in terms of scheduling the primary course and booster is particularly important and is highly relevant for beef cattle farmers as it can be difficult to know exactly when a cow is likely to calve and it is vital not to miss the vaccination window.
"Bovigen Scour is also convenient to give because of the small volume of emulsion and because the injection is given intramuscularly. Its launch extends our large animal vaccine range, which includes Gudair, for the active immunisation of sheep and goats against Mycobacterium avium subspecies paratuberculosis (Map)."
The BVA has expressed its concern that almost two-thirds of food companies have no information on their commitment to stunning animals before slaughter – with only 4% having a "universal commitment".
The findings were published in the Business Benchmark on Farm Animal Welfare report (BBFAW, published 27 January) and also show that slaughter without pre-stunning is the only welfare measure showing a decline in the percentage of food companies that have a specific policy on the practice, down from 34% in 2014 to 32% in 2015.
BVA has run a long-standing and high profile campaign to end non-stun slaughter in the UK, with a public petition in 2015 gaining 120,000 signatures. BVA, together with all leading farm animal welfare organisations, believes that all animals should be stunned before slaughter to render them insensible to pain. Scientific evidence supports the use of pre-stunning to safeguard animal welfare. In 2015, two-thirds of BVA members listed the issue as one of their top priorities for government.
BVA President Sean Wensley said: "Vets and the public are united in their concern about animal welfare at slaughter. There are several positive findings on the growing commitment of food companies towards farm animal welfare in the BBFAW report, which we welcome, but the report highlights a disappointing lack of commitment towards animal welfare at the time of slaughter. The European Commission’s study of 13,500 meat consumers across Europe found that 72% wanted information about the stunning of animals at slaughter. Food companies need to sit up and take consumers’ concerns about humane slaughter seriously. People want to be assured that farmed animals receive both a good life and a humane death."
Zoetis has launched a one-dose vial of Rispoval IntraNasal, in order to offer respiratory health protection in calves as soon as possible after birth without either waiting to batch them in groups or wasting unused vaccine in multi-dose packs.
To make ready for use, the vaccine is reconstituted by mixing a powder with sterile diluent. Once mixed, the licensed shelf life is two hours. This means any that is unused in multi-dose packs must be thrown away. By stocking a combination of one- and multi-dose packs, farmers can eliminate this.
The vaccine protects against two primary viral causes of pneumonia in young calves, BRSv and Pi3v1. Surveillance of blood samples from 2,145 calves with pneumonia signs found 78% exposed to BRSv, 81% to Pi3v2. The product licence allows use from nine days of age, with onset of immunity to BRSv and Pi3v after five and 10 days respectively. The licence also specifies a duration of immunity of 12 weeks.
Zoetis vet Carolyn Hogan says that viruses are the instigator of a majority of respiratory health problems: "Early-life protection also helps reduce the threat from opportunistic secondary bacterial infections, such as Pasteurella.
"Good respiratory health is essential to ensure calves develop to achieve their lifetime potential. But it's estimated that 67% of pneumonia cases occur in calves less than three months of age3.
"Whether suckled or reared, calves that don’t grow effectively in the early weeks are unlikely to catch up later. On both dairy and beef units, proactive management of the calf living space, nutrition and disease resilience is critical to maximise lifetime productivity, which is clearly so important under today's farm business economics.
More information about the benefits of managing respiratory health in calves is available at plantoproduce.co.uk.
The government has confirmed that tests carried out on a poultry farm in Dunfirmline have indicated the presence of a notifiable strain of avian influenza.
At this stage, officials say that the clinical picture indicates that this is a low pathogenic strain which poses little risk to human health.
All birds at the premises - 40,000 according to the Daily Mail - will be humanely culled, and a 1km Temporary Control Zone has been put in place to prevent the movement of birds, carcasses and eggs.
BVA President Sean Wensley said: "This suspected outbreak is further evidence of the vital surveillance role played by frontline vets in protecting animal and, by extension, human health. We commend the veterinary surgeon involved in detecting the outbreak in Fife, which has enabled a swift and effective response by the Scottish Government and all other organisations involved.
"We urge poultry keepers and vets working in the area to remain vigilant and to report any concerns to their local Animal Plant & Health Agency (APHA) office. We would like to emphasise that there is no food safety risk to the public."
Photo: RonaldDuncan at en.wikipedia
The BVA is calling on Defra and the APHA to take an innovative approach to capturing farm animal post-mortem data, after its Voice of the Veterinary Profession survey found that 90% of production animal vets now conduct their own PMs.
In 2014, there was a 31% increase in production animal vets carrying out their own PMs following post mortem laboratory closures, yet most vets keep this PM data at their practice, with less than 5% inputting it into a national system such as NADIS, AHT or APHA and less than 1% to a benchmarking group.
Sean Wensley BVA President said: "We have heard a lot about big data and its positive uses economically and socially. Disease surveillance could be a shining example of where big data and innovative data capture comes into its own. In a global world, where diseases such as Schmallenberg and bluetongue can emerge in our livestock without having previously been seen on these shores, being able to quickly join up the dots of disparate disease data is vital.
"We understand that Defra and APHA must make difficult choices due to economic pressures and we very much welcome research already utilising post mortem data such as the Agriculture and Horticulture Development Board’s Fallen Stock Project. What we now need is clear communications and guidance on carcase collection and access to PM examination arrangements together with a determination to see this as an opportunity to innovate, exploring how digital technology can help vets in the field record and capture data that feed into national databases and help us to see the bigger picture."
BVA is asking that all vets affected by laboratory closures are clearly informed about alternative arrangements for carcase collection and PMs, with 63% of vets affected by laboratory closures reporting that carcase collection in their local area was not working well.
BVA is calling on government and industry to lead in developing new and cost efficient ways to capture and analyse disease and surveillance data, drawing on innovations in digital technology and big data analysis.
Photograph courtesy BVA
Origin (previously known as Westpoint) has announced that FarmVets SouthWest has joined the group, giving further geographical coverage to its veterinary practice network.
FarmVets SouthWest has practices at Ilminster and North Petherton in Somerset and Honiton in Devon.
Eoghan McAlonan, a director of the practice, said: "We are delighted to be joining Origin. The Origin group delivers the highest standards in veterinary services to UK agriculture, and we will bring our farmer friendly services to further enhance the groups activities".
In turn Origin says it plans to bring the wide benefits of group membership, including lab services, dairy consultancy and paraprofessional services, to further enhance the high level of service the vet team at Farmvets SouthWest provide to producers in Somerset and Devon.
Jon Mouncey, Managing Director of Westpoint Farmvets, said: "Working alongside our other Origin practices in the South West region, we can now offer all livestock producers our advanced services, ensuring their stock receive the very best in veterinary care. Our group offers a unique approach to integrated veterinary services and by applying the latest technology and research we ensure that animal health and welfare is optimised, delivering real value for our clients in a challenging agricultural climate."
From today, porcine epidemic diarrhoea (PED) is a notifiable disease in England; veterinary surgeons and pig-keepers are now legally required to inform the Animal and Plant Health Agency of any suspicion of the disease.
If a test for PED proves positive, the Government will inform AHDB Pork, so that tracing can be carried out and improved biosecurity measures put in place.
The new measure has been introduced following co-operation between Defra APHA, AHDB Pork, the NPA and other industry bodies. Although PED is now classified as notifiable, there will be no statutory movement controls, no compulsory slaughter and no blocks on exports.
Under the new legislation in England, APHA will be legally permitted to inform AHDB Pork - which is the agreed 'appropriate organisation' - in confidence of suspect and confirmed cases. AHDB Pork will then provide biosecurity guidance to the pig unit concerned. It will also carry out tracing and alert at-risk contacts as necessary.
The aim will be to prevent spread of PED and to eliminate the disease from the pig unit. There will be no requirement to slaughter affected animals.
PED has been made lightweight notifiable following an informal consultation process with the pig industry. NPA and others called for the measure so that any outbreak can be identified as quickly as possible, spread can be prevented, and the disease can then be eliminated from the unit concerned.
AHDB Pork Chairman Meryl Ward said: "This initiative is a significant step change in partnership working between industry, Defra and the APHA to build England’s resilience to disease.
"PED is a potentially serious disease and emerging threat to our English pig industry. A unique industry led collaboration with Government led to the development of the PEDv Contingency plan to ‘identify, contain and eliminate’.
"The regulatory change to notifiable status is a critical part of the plan and will assist in early identification of affected premises, allowing more time to take effective actions to minimise the impact on the industry and therefore increasing the opportunity to eliminate the disease.
"Working together to share resource, knowledge and build vital expertise, the partnership has also developed a series of standard operating procedures, bio- security guidance as well as raising awareness across industry of the potential threat.
PED remains a significant threat to British pig-keepers. According to AHDB, outbreaks of high-impact strains caused up to 100% mortality in young pigs in the United States, knocking out around 10% of pig production in 2013-2014. The disease has since spread to Ukraine. Even with milder European Union strains, piglet mortality as high as 70% has been reported.
The Scottish Government is currently consulting on making PED similarly lightweight notifiable in Scotland.
The BVA and the Pig Veterinary Society (PVS) have welcomed the announcement. John Blackwell, Senior Vice President of the British Veterinary Association, said: "From today pig-keepers will be required to contact APHA if they have any suspicion of PED in their livestock - this is a step in the right direction and a result of joined up working between the industry, the veterinary profession and policy makers. PED is a devastating disease and we hope these measures will be sufficient to protect animals and pig-keepers in England from future outbreaks. We are encouraged by current proposals to make PED notifiable in Scotland and are keen to see similar measures in place across the rest of the UK."
Dr Mandy Nevel, President of the Pig Veterinary Society, said: "The Pig Veterinary Society was actively involved in the decision to make PED notifiable in England and we fully support the decision. Whilst we hope PED does not come into England, the legislation will facilitate rapid diagnosis, control and eradication in the event of a case occurring. We urge the rest of the UK to take similar action."
Photo: Ben Salter: Pig in a bucket
Barrettine Environmental Health has launched MiteMax, a new treatment for poultry red mite (PRM) with a physical mode of action.
Charles Phillips from Barratine said: "PRM poses a significant threat to laying hens particularly, with infestation costing the UK egg industry in excess of an estimated €3 million per annum through PRM control and lost production. In the UK, PRM is prevalent in varying percentages according to the rearing system used. Caged birds are estimated to have a variable 7.5 to 87.5 % prevalence. Free range systems are estimated to have 60 % prevalence of PRM, with organic systems higher at 78 %. Less intensive systems have a greater prevalence of PRM due to the higher number of cracks and crevices associated with a more enriched environment1."
MiteMax is applied directly to a shed’s inner surfaces via knapsack sprayer, rendering the surfaces sticky and permanently immobilising red mites that come into contact with them.
According to the company, the new product - which is designed to fit into and encourage integrated pest management practices - provides rapid knock-down of poultry red mite.
Charles added: "The physical mode of action of MiteMax makes it effective against pesticide-resistant mites. MiteMax is specifically formulated to penetrate surface dust making it highly effective at reaching mites harbouring deep in crevices."
In conjunction with robust cleansing practices, Ian Whelan an expert in physical insect control techniques says MiteMax fits neatly into an integrated pest management style of husbandry: "Using treatments with different modes of action together as part of a flock health plan ensures each one fulfils its potential."
MiteMax is available nationwide from Barrettine Environmental Health's appointed distributors.
Reference
The RCVS has brought out a new publication to help members of the veterinary and veterinary nursing professions understand their legal and professional obligations regarding controlled drugs.
Controlled Drugs Guidance is a consolidation of existing advice and guidance on controlled drugs from a number of organisations including the RCVS itself, the Veterinary Medicines Directorate (VMD), the British Small Animal Veterinary Association (BSAVA) and the Home Office. The guide also gives details of the existing legislation concerning controlled drugs, namely the Misuse of Drugs Act and associated regulations.
The guidance provides advice on a variety of topics to reflect the common queries the RCVS Advice Team receives, such as storage, destruction and disposal; keys and keyholders for controlled drugs cabinets; controlled drugs in vehicles; and veterinary nurses administering controlled drugs.
The publication also deals with specific controlled drugs such as ketamine which, on 30 November 2015, was rescheduled to a Schedule 2 controlled drug, meaning that it is now subject to the same strict storage, prescription, dispending, destruction and record-keeping requirements as other medicines in this Schedule.
Laura McClintock, Standards and Advisory Manager at the RCVS, said: “We hope that this publication will help members of the profession navigate the often complex legislative and professional requirements regarding controlled drugs, as well as imparting best practice advice on how they should be stored and disposed and so on.
"This publication has also been endorsed by our colleagues in the Home Office, VMD and BSAVA and, because this is an area that is subject to regular change, we will make sure to keep it up-to-date as and when the regulations change."
The publication is available to download from the RCVS website at www.rcvs.org.uk/publications
IDT Biologika and Hysolv Animal Health have announced the publication of A guide to oedema disease in pigs, a six-page booklet written to help pig producers understand the causes, effects and treatment of this ailment.
Author, F Javier Salquero, an independent European veterinary specialist in porcine health management, outlines the risk factors, how to identify oedema disease, current methods of treatment and prevention strategies. The booklet includes a table of the symptoms to be expected in new-born, suckling, post-weaned, grower-finishers and adult pigs.
The booklet concludes that treatment of oedema disease is generally unsuccessful and most pigs showing clinical signs die. However, preventive measures include adjustment of feeding regimes, stress reduction, improved biosecurity and vaccination.
Hysolv director, Richard Brealey said: "Oedema is a widespread, lethal and economically-important disease in pigs, and there is increasing pressure in Europe to reduce the use of antibiotics in livestock. Fully understanding this disease is a first step to control and prevention".
Hysolv says a German calculation showed a reduction in margin of 83 Euros (£74) per sow, equivalent to 41,000 Euros (£32,500) for a 500-sow herd, due to oedema.
The booklet — printed on heavy duty glossy card – suitable for use in piggeries — is available, free, by visiting the Hysolv website: www.hysolv.co.uk
Two new campaigns which call on the veterinary profession to unite against the practice of homeopathy have been launched this week.
Both campaigns raise concerns about the ethics of veterinary surgeons using irrational, unscientific and ineffective remedies to treat ill animals or in place of conventional vaccinations.
The Campaign For Rational Veterinary Medicine presents the case against homeopathy on a new microsite, and asks the profession to unite around a call for the Royal College of Veterinary Surgeons to issue a public position statement that homeopathy is ineffective in animals, bringing it into line with the NHS, the findings of the British government's own review of homeopathy, and the BVA.
The campaign also asks that veterinary surgeons who prescribe homeopathic remedies be required to get owners to sign a consent form, prepared by the College, giving the College’s views on the ineffectiveness of homeopathy.
Lastly, the campaign asks that promotion or advertising of homeopathy by veterinary surgeons should abide by Advertising Standards Authority regulations and carry a statement from the College.
The Campaign for Rational Veterinary Medicine has been set up by a group of practitioners including the BSAVA Past President, Mike Jessop, Alex Gough, Martin Whitehead, Niall Taylor, Phil Hyde, Martin Atkinson and Brennen McKenzie, supported by VetSurgeon.org Editor, Arlo Guthrie. It also has the support of the noted author, academic and erstwhile dog owner, Professor Edzard Ernst.
Arlo said: "This is not just about the ethics of prescribing or tolerating the practice of prescribing water to animals that are dependent on us. There are 13m pet owning households in the UK. As well as visiting the vet, they will all be patients at some stage in their lives. So what you and the College say about homeopathy in animals has the potential to affect the choices they make for themselves too. Think how much money and false hope you could save them, and the consequent benefit to human welfare."
By complete coincidence, another campaign against veterinary homeopathy was launched last week. This one, by Danny Chambers MRCVS goes further, calling for a complete ban on the prescription of homeopathic remedies by veterinary surgeons. The petition has already gathered over 750 supporters.
Arlo said: "I think it’s important to say that the two petitions are not mutually exclusive. If you think both represent acceptable solutions, then sign both!"
Visit the Campaign for Rational Veterinary Medicine here, and sign the petition here.
Sign Danny Chambers' petition on change.org here.
Dr Johanna Fink-Gremmels – Professor of Veterinary Pharmacology and Toxicology at Utrecht University – has warned that UK cattle producers need to plan for an on-going struggle with feed-borne mycotoxins, and says vets need to help farmers understand and mitigate the negative impact on animal health.
Speaking to cattle vets at a CPD meeting organised by Alltech, she said: "When you see a general inflammatory response, such as elevated somatic cell count, mycotoxicosis should always be on your radar. The mycotoxin threat to cattle is increasing in the UK, yet it is often the most neglected causative issue on any list of pathogenic suspects."
Johanna explained that natural toxins produced by diverse fungal species are proliferating worldwide, partly as a result of global climate change, but also because of changing agronomic practices in developed countries.
"Total mixed rations often now contain more than one fungal species, contributing to a complex mycotoxin picture and unresolved health issues in a herd as a result. Cow signals such as reduced feed intake, reproductive disorders, laminitis, mastitis, impaired liver function, a poor response to vaccination programmes and even increased susceptibility to bacterial and viral diseases can all be attributed to ingesting mycotoxin contaminated feed."
Johanna says the biggest challenge for UK dairy farmers is now multiple mycotoxin contamination of grass and maize silage.
"Cattle health problems with feeding obviously mouldy silage are relatively well understood. But new harder to detect fusarium toxins – such as, for example, Enniatins and Beauvericin contaminating cereal grains – are also now being found in pasture grass in Northern Europe. These will also adversely affect the efficiency and function of the rumen.
"The rumen determines the health and productivity of the cow. When rumen bacteria are suffering the liver does not function correctly initiating a cascade of adverse events; and often a generalised inflammatory response is triggered, which leads to a loss of production."
Johanna added that in the future farmers will need select feed crop plants that are more resistant to fungal invasion and will also have to re-adjust tillage methods to reduce mould contamination. "However, we know that this alone will not stamp out mycotoxin contamination without creating a biological vacuum that will be filled with other micro-organisms.
"Consequently, it will be essential to continue to apply strategies such as rigorous on-farm risk assessment and the use of appropriate in-feed mycotoxin-sequestration agents (binders) to prevent the production-limiting and adverse health effects in our farmed livestock."
Leading human and animal health organisations – the British Medical Association (BMA), British Dental Association (BDA), British Veterinary Association (BVA) and Royal Pharmaceutical Society (RPS) - have joined forces for the first time to promote a ‘One Health’ approach to ensure responsible guardianship of antibiotics and their proper public use on European Antibiotics Awareness Day tomorrow.
Antibiotics are obviously a vital medicine for both animal and human health, and modern health systems rely on the availability and effectiveness of a range of antimicrobials to treat and prevent infections. Yet inappropriate use – such as prescribing for self-limiting infections, not finishing a prescribed course of antibiotics or habitual prophylactic use in healthy animals to prevent disease - all contribute to the development of resistant bacteria in both humans and animals.
Whilst antibiotic resistance in animals does not perhaps present the greatest immediate existential threat, there is a strong argument for a united message to the public coming from doctors, dentists, chemists and veterinary surgeons.
Quite simply, some 13M households own a pet. Pretty much all of them visit a vet at some stage, and most will be a human patient at some point in their lives. So, what a veterinary surgeon says about the use of antibiotics in animals has the potential to help transform how owners think about them when they come to visit the doctor.
A survey of general practitioner doctors last year found that 90% feel pressured by patients to prescribe antibiotics and 28% have prescribed them several times a week when not sure they are medically necessary. If veterinary surgeons refuse to prescribe them for pets unless medically necessary, explaining that they are a precious resource which can no longer be wasted, it could help relieve the pressure on doctors. The same goes for the importance of compliance; if owners learn the importance of their pet taking the full course, there's a greater chance they'll understand why they need to complete their own course of treatment.
BVA President Sean Wensley said: "Antimicrobial resistance (AMR) is too important an issue for uncoordinated approaches amongst the medical professions. We need to work together to share knowledge and successful approaches, as well as taking responsibility for not just the immediate clinical situations before us, but also for our role in supporting the health and wellbeing of wider society. An effective approach to tackling AMR is about professions and patients working together for the greater good."
BMA board of science Chair Professor Sheila the Baroness Hollins said: "Doctors have expressed significant concern about the threat of a ‘post-antimicrobial age’. It is vital that we see action to improve antimicrobial prescribing across all disciplines. Only by different professionals working together to improve antimicrobial stewardship will we start to address this major public health issue."
BDA President Professor Nairn Wilson said: "All health professionals have a responsibility to draw a line under inappropriate or unnecessary use of antibiotics. One in ten prescriptions in the UK are provided by dentists, so we’re determined to do our bit. We are facing a clear and present danger to public health, and it will only be overcome if we act together."
For further information about EAAD 2015, visit www.ecdc.europa.eu/en/EAAD
To mark EAAD 2015, BVA has produced a range of new posters to promote the responsible use of antibiotics for use in veterinary practices or as a source of information for pet owners which can be found on their website www.bva.co.uk/eaad.
The Westpoint Group has announced the divestiture of its small animal and equine veterinary practices in order to focus on production animal health and welfare.
From now, the production animal business - which includes veterinary practices providing services to pig, poultry, dairy, beef, sheep, game bird producers and small holders - will be known under the umbrella brand of Origin.
The company says that excellence and innovation in client service will continue to be the focus throughout the organisation.
Matt Dobbs, Managing Director of Origin said: "Origin is committed to supporting livestock farmers to enhance production by improving health and welfare. We have a unique group of vets, researchers, lab techs and paraprofessionals passionate about the success of UK agriculture, with other businesses committed to supporting the industry, joining us through the autumn.
"By focusing on supporting farmers, we will become a unique source of animal insight in livestock agriculture."
For more information, visit: http://www.westpointveterinarygroup.com
The industry-led Cattle Health and Welfare Group of Great Britain (CHAWG) has published a review which identifies a practical approach to gathering antibiotic usage data on UK cattle farms.
The review outcomes, announced today at a joint conference held by the Responsible Use of Medicines in Agriculture Alliance (RUMA) and the Veterinary Medicines Directorate (VMD), highlight the significant benefits better data could deliver, such as improving the way antibiotics are administered strategically to tackle disease.
But CHAWG’s chair Tim Brigstocke says it’s also important that the industry is able to accurately report usage levels because of the rising levels of antibiotic-resistant bacteria which threaten human health.
"We found that while data is already stored at every vet practice and in every farm medicine book, it currently exists in many different forms. It’s also not collected or collated, and is further complicated by multi-species approvals for many of the antibiotics.
"This means we can’t always be sure in which type of animal a medicine has been used. For example, out of 420 tonnes of animal-authorised antibiotic active substance sold in the UK in 2013, only 14 tonnes was authorised solely for use in cattle. However, 63 tonnes was authorised for multi-species use in food producing animals and within the 217 products included in this, 201 are authorised for use in cattle."
Tim says that with the support of the VMD, which requested the review and will now act as secretariat, CHAWG will set up a working group to implement the report’s recommendations.
The starting point is likely to be the survey of vets carried out by the British Cattle Veterinary Association (BCVA), which formed part of the review. This suggested vets could be using as many as 15 different software programmes to log data, so CHAWG will be working with the BCVA and individual practices to look at how standard sets of data can be anonymised and exported.
"Then we will almost certainly look at how cattle farmers can be supported in migrating records from the physical ‘medicine book’ on the farm, into a spreadsheet or existing cattle management software for anonymous aggregation on a national level.
"There are undoubtedly areas where we can improve the effectiveness of how we use these powerful medicines to improve welfare. But the antibiotic resistance debate is an emotive one and we must also demonstrate accountability to ensure the preservation of antibiotics for future use in humans and animals; any future curbs on usage should be proportionate and informed, and not compromise animal wellbeing."
Mandatory reporting in Europe could be just over the horizon and the European Medicines Agency has focused in the past year on developing a method for data collection on the usage of antibiotics in the EU pig sector. In the UK, the VMD is encouraging the livestock sectors to develop systems appropriate to their own unique circumstances and industry characteristics.
Tim said: "It’s therefore in cattle farmers’ own interests to anticipate the kind of figures it might be asked to supply in the future, and develop a way of collecting that data which suits the way the UK industry works.
"Then we can retain control over the data and the methodology, and ensure the reporting is accurate – and this in turn will help the VMD represent our case better in Europe as this debate continues.
CHAWG says that throughout this project, it will be liaising with others – such as the pig sector – to ensure learnings are shared, duplication avoided and efficiencies realised where possible.
The CHAWG review report is available to download at www.chawg.org.uk.
The National Office of Animal Health has issued a statement criticising the All Party Parliamentary Group on Antibiotics report: "Non-human uses of antibiotics: time to restrict their use?”, saying it fails to recognise the steps that have already been taken by vets and farmers to prevent disease and minimise antibiotic use on farms where possible.
NOAH chief executive Dawn Howard said: "NOAH fully supports the need for responsible prescribing, by both the veterinary and medical professions.
"On the veterinary side, NOAH has been very actively involved with responsible use initiatives, such as the RUMA Alliance, which publishes guidelines supporting responsible use and has produced an action plan on livestock antibiotic resistance to implement Government strategy.“
NOAH highlights two particular aspects of the report. Firstly that it is critical of the treatment of groups of animals through medicated feed and water.
Dawn said: "There are many animal-friendly reasons why medicines can be prescribed in this way by a veterinary surgeon.
"For groups of animals, fish or birds there is less stress than injection or individual oral dosing. Where treatment is needed, the vet supplies a prescription for treatment through medicated feed or through the water, depending on the product being used. The whole process is highly regulated through European and national legislation."
The report also suggests certain classes of antibiotics should be reserved for humans. NOAH says it believes that veterinary surgeons need to retain the full range of currently licensed antibiotics in order to be able to treat the range of conditions that affect animals, and if they are restricted, animal welfare will undoubtedly suffer.
NOAH adds that removal of some classes from the veterinary sector would place undue selective pressure on the remaining classes which could increase resistance to those classes – having the opposite effect to what the committee probably intends.
Dawn said: “NOAH is disappointed not to have been consulted in advance of the publication of the report. We believe that responsible use of veterinary antibiotics is the best way to help preserve these precious medicines for us all, without compromising the health and welfare of our animals.”
BCF, Instrumentation Concept and VetSonic have collected 'VetSurgeon.org Best Stand Awards'; the first two at BEVA Congress and the latter at BCVA Congress.
Judging for the BEVA Congress awards was undertaken by members of BEVA Council. BCF picked up the Best Large Stand Award which was presented by outgoing President, Andrew Harrison.
Pictured left to right: BEVA President, Andrew Harrison, Gavin Mitchell and Carole Irvine of BCF, and John Alborough representing VetSurgeon.org.
Instrumentation Concept picked up the Best Shell Scheme Award
Pictured left to right: Outgoing BEVA President, Andrew Harrison; Tahir Afzac of Instrumentation Concept; John Alborough representing VetSurgeon.org, and Sheraz Ishaque of Instrumentation Concepts
At BCVA Congress, Vetsonic won the Best Stand Award.
Pictured left to right: Clare Walsh, Vetsonic Director; John Alborough, All Round Good Egg representing VetSurgeon.org; Gareth Hateley, then President BCVA and Sarah Vermont, Marketing Manager Vetsonic.
Norbrook has launched an Android version of its existing free iPhone app: ‘the Veterinary Excellence Tool’ (VET).
VET offers a range of functions to assist veterinary professionals and farmers including a product dosing calculator. The Android version has been developed to meet customer demand and has the same features as the Apple version which is available for both iPhones and iPads.
Norbrook highlights the following features of the app:
The app can be downloaded for free by searching for “Norbrook” in either app store.
For further information please contact Laura Holmes, E-Marketing Manager, laura.holmes@norbrook.co.uk or 01536 741147.
The Society of Practising Veterinary Surgeons (SPVS) is putting out a last call to take part in the SPVS Salaries Survey 2015, open to everybody working in the veterinary profession.
The long-standing survey provides a benchmark for veterinary surgeons, nurses and support staff to see trends in pay and conditions. Designed to provide a complete picture of remuneration levels, the survey covers basic earnings, bonuses, dividends, overtime and benefits such as accommodation, car allowances, private medical insurance and pensions. It also includes questions on employment contracts, hours worked, out of hours and weekend working.
Peter Brown, SPVS Treasurer and author of the Salaries Survey said: “I have been compiling the survey results for a number of years but it never fails to enlighten me as to what is happening in the profession. I know it is also the go to reference guide when practices are recruiting to help ensure they are offering competitive salary packages.
“Participation in the survey is open to all and the more practices that take part, the more accurate and useful the information will be so we would urge everyone working in the veterinary profession to take a few minutes to complete the survey. It can be done online and the information is completely anonymous.”
To complete the survey online, visit www.spvs.org.uk or, for a printed version, telephone 01926 410545. The survey is open until 30 November 2015.
Virbac has announced that its recently launched parasiticide Neoprinil has been granted a shelf life extension from one to two years after first opening.
The company says the extension will help minimise the risk of wasted product and increase its convenience to farmers.
An eprinomectin pour-on solution, Neoprinil is indicated for use against internal and external parasites in cattle, including gut and lungworms, mange mites, sucking and chewing lice, horn flies and warbles. It is administered using the company's Farmpack and Flexibag, and offers a zero-day withdrawal period in milk.
Virbac's Product Manager for Large Animals Brigitte Goasduf MRCVS said: "Understanding the challenges our customers face and offering products to overcome them is our goal so we are delighted that Neoprinil has received a shelf life extension because this adds to its flexibility and convenience for farmers. It also brings it into line with Deltanil, our deltamethrin-based pour-on for use against a range of ectoparasites in cattle and sheep.
"We now offer a comprehensive and flexible parasiticide range administered with a dispensing system that sets a new standard for convenience and ease of use."
Neoprinil is presented in 2.5l, 4.5l and 8l pack sizes.
Hysolv Animal Health has announced that it is offering a free swine flu laboratory diagnostic service to veterinary surgeons in the UK and Ireland.
The company will supply kits to veterinary surgeons with which to take samples from pig herds they suspect are infected with swine flu. The samples, nasal swabs or blood, will be sent direct to Germany where vaccine and biological company IDT Biologika is using a special facility to detect which viruses or antibodies against certain serotypes are present.
The virological tests will be conducted by the Institute for Virus Diagnostics, part of the Federal Research Institute for Animal Health. Antibody titres against H1N1, H1N2, H3N2, panH1N1 and panH1N2 will be looked for. Hysolv says these tests, including histopathology, can provide the only conclusive proof of influenza infection.
Results from the test — which would normally cost 230 Euros (about £185) to conduct — will be available within a week. IDT is believed to be the first company offering this type of test.
According to the company, the PCR test — from nasal swabs — is much more precise than previous testing regimes and will identify and type circulating strains as well as emerging strains.
Hysolv says that when swine flu strikes a farm, the signs seen are no longer just typically flu-like but a show whole range including fever, coughing, dyspnoea as well as returns to oestrus and abortions in sows. These may be in combination and concurrent with other diseases which makes accurate diagnosis difficult.
IDT will be offering the newly-branded vaccine Respiporc Flu 3 where the veterinary surgeon feels vaccination in indicated.
Hysolv director Richard Brealey said: “IDT is raising the bar in flu testing and this is a significant advance on what has been done in the past. In 2014 one-third of 1353 nasal swabs sent for testing proved positive for swine flu in Germany. In the UK the samples will help give an insight into the epidemiological status quo of the national pig herd.”